Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Moderately Severe Crohn's Disease
NCT00446433Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Mar 2002
- Countries
- 4
01
Overview
A Phase 2 trial of lenalidomide in Crohn's disease, sponsored by Celgene Corporation. Started Mar 2002; status: completed.
02
Drugs
lenalidomide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00446433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446433.